Pancreatic cancer:
personal notes of Dr.. Claudio Italiano,
gastroenterologist hospitals
Who writes on its experience, has had several patients with this severe form of
cancer for which early diagnosis or knowledge of a genetic predisposition and
family are the foundation of successful therapy. In fact, if you know of a sense
of familiarity in the development of cancer, you must submit to screening and
prevention appropriate family members. This writer, unfortunately, after a long
time, has managed the diagnosis of a man treated for ulcers and found suffering
from irritable bowel syndrome! Let us remember that the cure is always the last
act of a diagnostic! To this gentleman, having performed an ultrasound and a CT
abdomen and that, therefore, a magnetic resonance imaging, was found a
suspicious lump. Performed a targeted biopsy, but the tumor was found already
extended to the vessels and the peritoneum. The same was treated and palliation,
the best thing to say is that he was concerned about the health of loved ones,
until the end because he had an account of illness that gripped him.
Epidemiology.
The risk of developing pancreatic cancer increases with age, so that before age
60 are rare: Apennines in 15% of cases, 50% spread, however, between 60 and 80
years, 25% of cases spread over 80 years.
The causes of pancreatic cancer include:
Hereditary in 10%, or if there is familiarity, if the father is ill, his son
will become ill.
In 30% of cases it is always smoking smoking is a major cause of cancer of the
pancreas and beyond.
Benign lesions in the 4% of cases
The diet in 20% of cases contributes to the etiology.
In 36% of cases you do not know why.
And we mean when we talk about diet, high consumption of meat, foods high in
cholesterol, fried foods and nitrosamines with sausages (eg salami), while fruit
and vegetables seem to reduce risk. Even obesity, weight and general lack of
physical activity play a key role, it was shown that obesity is frequently
associated with pancreatic cancer (Michaud et al. JAMA, 2001;
A recent meta-analysis about the occupational risk to develop cancer (from
exposure to environmental carcinogens) was conducted in 92 studies, grouping 23
carcinogens, showed that the substances are responsible for developing segienti
in percentages:
· CHC solvents 1.4%
· Nickel compounds in nickel with 1.9%
· Chromium and chromium compounds 1.4%
· Polycyclic aromatic hydrocarbons 1.5%
Insecticides · organocloridici 1.5%
· Silicon powder 1.4%
· Solvents of aliphatic hydrocarbon and alicyclic 1.3%
Cystic fibrosis and cancer.
Cystic fibrosis plays a role, since cancer is a very rare event in patients with
cystic fibrosis. Cancer in these individuals is five times more frequent than
the general population, but people with cystic fibrosis are less than 40 years,
or less of subjects suffering from pancreatic cancer, so this is not significant
reduction of incidence. Since the age of these subjects tends to rise over time,
probably cancer may become more frequent in these populations.
Genetic mutations and pancreatic cancer.
Lal and colleagues studied 102 cases of cancer of the pancreas in Ontario. Based
on the history of their family, 38 of these patients were classified as high
risk for a genetic mutation identified in 5 of them (1-p16, the BRCA1-and
BRCA2-3). Four of these patients have associated cancer with this mutation.
Known cause of genetic predisposition are important factors in only a small
percentage of tumors of the pancreas. In these subjects because of smoking or
not is due to early development of cancer in a study that proved as 16 subjects
who developed cancer were smokers, and others who were not only developed it
after 20 years in the ' (Lowenfels et al. JAMA, 2001). The effect of these
mutations and to study these genetic predispositions is that they are to be
screened.
Histology
Malignant tumors are the most frequent tumors of this body, representing 2% of
all malignancies and 10% of those of the gastrointestinal.
The malignant tumor of the pancreas, or carcinoma is more common in men and in
women (ratio 1.5:1) and in recent decades has presented a significant increase
in frequency. Benign tumors are rare, accounting for 60-10% of neoplasms of the
pancreas. The most frequent are divided into:
Solid serous cystic adenomas
solid mucinous cystic adenomas
These tumors must be differentiated from simple cysts that often appear in
patients with a history of pancreatitis (inflammation of the pancreas).
Extremely important is the early diagnosis of mucinous cystadenoma is considered
as a possible precursor of cancer. More often appears in the 6th decade of life
and is currently the 4th-5th cause of cancer death in Western countries.
We distinguish:
Ductal adenocarcinoma (75-90% of cas, the most common) The most frequent
localization is dependent of the head (65%), while more rare is the involvement
of the body (30%) and tail (5%).
Mucinous adenocarcinoma
Acinar cell carcinoma
Adenosquamous carcinoma
Anaplastic carcinoma
Carcinoma cells with signet
Carcinoma mixed endocrine cells and ductal
Giant cell tumor-like osteoclastic
Mucinous cystadenocarcinoma
Intraductal papillary carcinoma
Pancreatoblastoma
Cell carcinoma solid pseudopapillari
The symptoms most commonly occur in pancreatic cancer are:
pain
dyspepsia (digestive slow, laborious, nausea, vomiting)
weight loss
jaundice (yellowing of the skin, as the side represented by our case report)
ascites in end-stage for peritoneal metastasis (ascites tumor)
1 The pain occurs for infiltration or compression of the nerve plexus, and is a
pain like "belt", assumes that a distribution with involvement of upper quadrant
abdominal irradiation and back to back, around the waist of a person.
Dyspepsia, the most frequent cancer in the head, is generally characterized by
anorexia, nausea, vomiting and beehive irregularities (constipation alternating
with diarrhea).
Weight loss is not always present, is related to dyspeptic symptoms described
above as well as malabsorption resulting from the impaired function of exocrine
pancreas.
Jaundice is a more consistent and early sign of cancer of pancreatic head
(80-90%) but much less frequent and late in tumors of the pancreatic body and
tail. E 'due to compression and / or invasion of the bile duct and is associated
with itching, stool and urine ipocoliche hyperpigmentation.
The appearance of most common presentation of cancer of the pancreas is a hard
nodule that invades surrounding tissues and it is clear a net margin. In the
case of cysts you will detect the presence of groupings and microscopically well
demarcated internally containing liquid material and / or mucous.
Diagnosis
Tumors of the pancreas are difficult to diagnose, especially in the early stage
because symptoms are often very hazy and nonspecific. In addition, the pancreas
is located deep in the abdomen and is thus difficult to study by conventional
instrumental methods. These include:
laboratory tests - tumor markers CEA and CA 19.9
radiological:
ultrasonography - is the first survey instrument, easy to use. Possible to
evaluate the bile ducts (for the presence of stones) and changes in morphology
in the structure of the pancreatic gland.
CT abdomen - this test allows proper assessment of the lesion.
MR cholangiopancreatography - often the integration of CT. Permits evaluation of
vascular structures adjacent to the tumor and the morphology of the pancreatic
duct of Wirsung.
ERCP (endoscopic retrograde cholangiopancreatography) - this survey through the
injection of contrast medium directly into the urinary tract (bile duct-bile
duct and pancreatic duct) is extremely reliable and accurate.
Biopsy - phased out for the increasing reliability of the instrumental and the
risk of dissemination of neoplastic cells along the needle passage.
When operate?
And 'contraindicated if you are:
· Liver metastasis, peritoneal distance
Infiltration · vascular obliteration (axis mesenteric-portal, superior
mesenteric a., hepatic a.)
· Relatively contraindicated if there is a portal-mesenteric axis tangential
involvement and infiltration of duodenum and colon of the cave pyloric.
In any case, the excision must be complete, with resection margins free of tumor
(VBP, isthmus-body area, posterior pancreaticoduodenal, retroperitoneal margin),
the extended lymphadenectomy to the level II lymph nodes, removal of self
extrapancreatic nerve plexus (plexus capital , the A complex.
pancreaticoduodenal)
Surgery is currently the only effective treatment in this condition. The 5-year
survival does not exceed 6% for tumors of the pancreatic head, while for tumors
of the papilla of Vater is 40% (usually the diagnosis is early for the immediate
onset of jaundice). Radical resection depends on the location of the tumor, but
given the increased frequency of cancers of the head of the pancreas is the most
common intervention duodeno-cephalo-pancreatectomy, which is the removal of the
duodenum with the head of the pancreas, bile terminal and possibly the last
portion of the stomach (pylorus). Together all regional lymph
node are removed........
e- mail E-MAIL here
>>>see first page
>>>see also RICERCA